A molecular biologist by training, Madison immersed herself in the CGT landscape during her 2+ total years as a DHC intern before joining as a full-time Analyst in September of 2025.
CMC
A molecular biologist by training, Madison studied mechanisms of genetic recombination, DNA damage repair, and genome engineering in a lab at the University of Miami Miller School of Medicine. Through her research project exploring the genetics of the radiation-resistant bacterium Deinococcus radiodurans, she gained hands-on experience in molecular cloning, plasmid design and application, and bacterial genetics by building a library of recombinant DNA constructs using non-viral mobile genetic elements. Madison immersed herself in the CGT landscape during her 2+ total years as a DHC intern, gaining comprehensive exposure to manufacturing, analytical, and regulatory aspects of viral and non-viral gene therapies before joining as a full-time Analyst in September of 2025.
Madison's introduction to the field of cell and gene therapy began during her recurring internships at DHC, where she immersed herself in the cell and gene therapy landscape and gained comprehensive exposure to manufacturing, analytical, and regulatory aspects of viral and non-viral gene therapies.
University of Miami
B.S. in Biochemistry and Molecular Biology
